[HTML][HTML] Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
BACKGROUND Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
[HTML][HTML] Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
S Gates, GD Perkins, SE Lamb, C Kelly, DR Thickett… - 2013 - ncbi.nlm.nih.gov
Background: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
[HTML][HTML] Beta-Agonist Lung Injury Trial-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
S Gates, GD Perkins, SE Lamb, CE Kelly… - Health Technology …, 2013 - wrap.warwick.ac.uk
Background: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of …
S Gates, GD Perkins, SE Lamb, C Kelly, DR Thickett… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
[HTML][HTML] Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
S Gates, GD Perkins, SE Lamb, C Kelly… - Health Technology …, 2013 - europepmc.org
Background Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
[PDF][PDF] S Gates, GD Perkins, SE Lamb, C Kelly, DR Thickett, JD Young
DF McAuley, C Snaith, C McCabe, CT Hulme, FG Smith - researchgate.net
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled
trial and economic evalu Page 1 HEALTH TECHNOLOGY ASSESSMENT VOLUME 17 ISSUE …
trial and economic evalu Page 1 HEALTH TECHNOLOGY ASSESSMENT VOLUME 17 ISSUE …
[HTML][HTML] Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
S Gates, GD Perkins, SE Lamb… - Health …, 2013 - research.birmingham.ac.uk
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of …
S Gates, G Perkins, S Lamb, C Kelly… - Health technology …, 2013 - ora.ox.ac.uk
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
[HTML][HTML] Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion …
S Gates, GD Perkins, SE Lamb, C Kelly, DR Thickett… - europepmc.org
Background: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in
intensive care patients and lacks effective treatments. A previous randomised controlled …
intensive care patients and lacks effective treatments. A previous randomised controlled …
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of …
S Gates, G Perkins, S Lamb, C Kelly… - Health technology …, 2013 - ora.ox.ac.uk
Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care
patients and lacks effective treatments. A previous randomised controlled Phase II trial …
patients and lacks effective treatments. A previous randomised controlled Phase II trial …